Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
18 EUR | -1.10% | +14.21% | -32.84% |
Apr. 09 | BASTIDE LE CONFORT MEDICAL : EPS upgrade (2023: 0.0%, 2024: +1.6%) | |
Apr. 09 | Bastide: new contract with the British NHS | CF |
Sales 2024 * | 530M 566M | Sales 2025 * | 564M 602M | Capitalization | 133M 142M |
---|---|---|---|---|---|
Net income 2024 * | 16M 17.07M | Net income 2025 * | 22M 23.48M | EV / Sales 2024 * | 0.89 x |
Net Debt 2024 * | 337M 359M | Net Debt 2025 * | 331M 353M | EV / Sales 2025 * | 0.82 x |
P/E ratio 2024 * |
7.88
x | P/E ratio 2025 * |
5.77
x | Employees | 3,635 |
Yield 2024 * |
2.61% | Yield 2025 * |
2.69% | Free-Float | 44.92% |
1 day | -1.10% | ||
1 week | +14.21% | ||
Current month | +27.66% | ||
1 month | +27.66% | ||
3 months | -15.89% | ||
6 months | -14.69% | ||
Current year | -32.84% |
Managers | Title | Age | Since |
---|---|---|---|
Vincent Bastide
CEO | Chief Executive Officer | 54 | 97-12-28 |
Corporate Officer/Principal | 50 | 15-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Vincent Bastide
CEO | Chief Executive Officer | 54 | 97-12-28 |
Vanessa Giraud
BRD | Director/Board Member | 50 | - |
Olivier Mares
BRD | Director/Board Member | 47 | 19-07-17 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 18 | -1.10% | 21,889 |
24-04-29 | 18.2 | +3.29% | 19,573 |
24-04-26 | 17.62 | +5.13% | 30,215 |
24-04-25 | 16.76 | +0.48% | 13,661 |
24-04-24 | 16.68 | +6.38% | 17,669 |
Real-time Euronext Paris, April 30, 2024 at 11:35 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-32.84% | 143M | |
-3.17% | 3.01B | |
-.--% | 1.83B | |
+3.55% | 1.55B | |
+50.22% | 628M | |
-2.51% | 506M | |
-39.53% | 345M | |
-11.23% | 140M | |
+5.77% | 70.32M |
- Stock Market
- Equities
- BLC Stock